HOME >> BIOLOGY >> NEWS
A New Molecular Marker For Prostate Cancer

LOS ANGELES, June, 16, 1998 -- A new molecular marker can be used to better predict tumor progression in men with prostate cancer, the second-leading cause of male cancer deaths in the United States. Researchers at the USC/Norris Comprehensive Cancer Center report the new findings from a study of 96 men with localized disease in the June 17 issue of the Journal of the National Cancer Institute. The team found that patients with tumors expressing abnormally low levels of a protein important in regulating cell division faced a significantly higher risk of disease recurrence and death than patients with tumors expressing high levels of the protein.

"Physicians may be able to use this tumor marker to identify prostate cancer patients most likely to harbor dangerous, life-threatening tumors," says Richard J. Cote, M.D., who led the study team. Cote is an associate professor of pathology and urology at the USC/Norris Cancer Center.

"In addition, the marker can help doctors make better decisions about treatment, ensuring that men most likely to develop metastatic disease undergo aggressive therapies. It will also help identify men who can avoid the most intensive and expensive treatments," he says. The American Cancer Society estimates that this year 184,500 American men will be diagnosed with prostate cancer and that some 42,000 men will die of the disease. With one of the highest incidences of all cancers, it is the second-leading cause of cancer deaths in men. Gauging how aggressive prostate tumors are -- and thus how aggressive treatment should be -- has created a quandary for physicians and men diagnosed with early prostate cancer.

In the last decade, the widespread use of the prostate specific antigen (PSA) test has allowed the detection of many more cases of early prostate cancer than previously possible. Yet, scientists believe that many of the localized tumors identified by the PSA screen are so slow-growing that men are more likely to d
'"/>

Contact: Eva Emerson
eemerson@hsc.usc.edu
213-442-2830
University of Southern California
16-Jun-1998


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
Cached News: